Very early researchWithdrawnNCT02774512
What this trial is testing
Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer
Who this might be right for
Colon Cancer
Institut Bergonié
Showing 20 of 0 results